# Safety and Tolerability Study of FG-3019 in Participants With Idiopathic Pulmonary Fibrosis

> **NCT00074698** · PHASE1 · COMPLETED · sponsor: **Kyntra Bio** · enrollment: 21 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **DRUG:** FG-3019

## Key facts

- **NCT ID:** NCT00074698
- **Lead sponsor:** Kyntra Bio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12-08
- **Primary completion:** —
- **Final completion:** 2004-05
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2023-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00074698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00074698, "Safety and Tolerability Study of FG-3019 in Participants With Idiopathic Pulmonary Fibrosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00074698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*